Scanning ultrasound to potentially treat Alzheimer's disease has been found to be safe and well tolerated in a first-in-human pilot study conducted by University of Queensland researchers.
Ceretas News
Ceretas awarded $2.4 million Government Grant for breakthrough Alzheimer’s therapy
Brisbane-based company Ceretas has been awarded a $2.4 million grant to fast-track development of its next-generation therapeutic ultrasound device - an Australian-designed innovation aiming to transform the treatment of Alzheimer’s disease.
Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions.
UQ ultrasound treatment for Alzheimer’s licensed to new startup
Ceretas has officially licensed a groundbreaking ultrasound technology from The University of Queensland that offers a promising non-invasive treatment for Alzheimer’s disease. Developed by UQ researchers, this technology temporarily opens the blood-brain barrier to...